Finnish medical technology company Optomed Ltd. has received 4 million euros from Chinese Cenova Ventures. Optomed will use the injected capital to boost their business in China.
– Receiving Chinese VC money can help a Finnish life science company to grow more than money collected from an investor from another country. It seems that European startups can offer good quality technology with competitive valuations to Chinese investors, says Optomed’s CEO Mr Seppo Kopsala.
Cenova Ventures met with Optomed the first time at a Golden Bridge investment event organized in China in 2012. After the initial introduction, both parties were keen on continuing discussions with each other. Golden Bridge provided background support for both sides throughout the investment process.
– Cenova Ventures has been very valuable for us. With the help of the local investor, we have been able to complete things that we otherwise could not possibly have been able to achieve in China with such a short time frame. Without Golden Bridge’s support, this would not have happened, Kopsala says.
Founded in 2004 in Oulu, Optomed specializes in digital imaging devices both for human and veterinary medicine. Optomed has established close collaboration with top universities, research institutions, physicians and specialized technology partners in Finland.
Optomed’s key product is Smartscope® M5, which is a modular hand-held retinal camera for screening and diagnosis of various eye diseases such as diabetic retinopathy, glaucoma and AMD. According to Optomed, Smartscope® M5 is the smallest product on the market with high image quality that fulfills international ISO 10940 fundus camera standard requirements.
Headquartered in Shanghai China, Cenova Ventures is a premiere Chinese venture capital firm that focuses solely on investing into life sciences and healthcare companies with main operation and potential in China.
Prestigious Chinese government investors and global multinationals support Cenova Ventures funds. With deep roots in China, global operational experience and solid working relationships with significant governmental entities, Cenova Ventures is strategically positioned to make synergistic investments in sub-sector leaders, building important infrastructure in the evolving Chinese life sciences and healthcare industry.
